Prostate cancer continues to be one of the main causes of cancer-related deaths among men in Portugal and worldwide. As a urologist dedicated to the diagnosis and treatment of this pathology, I witness daily the importance of early and accurate diagnoses in the effectiveness of treatment and the quality of life of patients. Among the most relevant advances of the last decade, fusion prostate biopsy stands out. This technology has revolutionized the way clinically significant prostate cancer is diagnosed . From a systematic approach to millimetric precision Traditionally, prostate biopsy was performed systematically, with the random collection of 12 to 14 fragments of prostate tissue, often without being able to consider the precise location of suspicious lesions. This method, although useful, has important limitations, the main one being that it can fail to detect clinically relevant tumors. Prostate fusion biopsy emerged as a direct response to these limitations. Combining multiparametric magnetic resonance imaging with real-time transrectal ultrasound, this technique allows the biopsy needle to be guided with precision to the most suspicious areas . Unquestionable clinical advantages The main advantage of fusion biopsy is its ability to significantly improve the detection rate of clinically significant cancers , which are those that truly require treatment, while reducing the identification of indolent lesions. International studies have shown that this technique increases the detection rate of high-grade tumors by more than 30%, compared to systematic biopsy alone. Furthermore, fusion biopsy plays a crucial role in active surveillance, allowing the evolution of lesions to be monitored with greater reliability , and is a fundamental tool in the reassessment of patients with previous negative biopsies but with persistent clinical suspicion. Portugal at the forefront Fortunately, reference centers in Portugal have adopted this technology with enthusiasm and competence. The integration of fusion biopsy as the gold standard in clinical practice places our country at the forefront of European urology, allowing Portuguese patients to have a level of care equivalent to the best international standards. The future is already here Prostate fusion biopsy represents a qualitative leap in the fight against prostate cancer. It is not just a technological innovation; it is a true advance in the approach of a disease that affects thousands of Portuguese men every year. With it, we take another step towards personalized, more effective and less invasive diagnosis. As a urologist, it is a privilege to be able to offer my patients this level of diagnostic accuracy. I firmly believe that the medicine of the future is built with today's technology and the same human commitment as always: to provide care with rigor, empathy and vision. Author : Ivo Lopes (urology) Meet the urology clinical team from Hospital da Luz network and book your consultation. Additional information about fusion biopsy . The content published in the Health Guide is intended for the general public and is provided for informational and educational purposes only. It does not replace individual medical assessment, diagnosis, or personalized clinical advice from a qualified healthcare professional. The content is produced or reviewed by physicians and other healthcare professionals at Hospital da Luz and is based on the knowledge available at the time of publication or the most recent update, as indicated at the beginning of each item.
